MiMedx Group, Inc.
MDXG
$4.36
-$0.05-1.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.99% | 14.77% | 6.85% | 5.34% | 8.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.99% | 14.77% | 6.85% | 5.34% | 8.52% |
| Cost of Revenue | 21.54% | 24.31% | 19.47% | 15.29% | 9.96% |
| Gross Profit | 19.67% | 12.87% | 4.34% | 3.37% | 8.23% |
| SG&A Expenses | 23.02% | 20.95% | 14.78% | 2.36% | 0.04% |
| Depreciation & Amortization | -42.41% | -33.94% | -23.26% | -11.55% | 0.13% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.51% | 21.61% | 15.66% | 5.03% | 1.83% |
| Operating Income | 7.72% | -15.23% | -31.72% | 7.11% | 59.81% |
| Income Before Tax | 15.66% | -7.07% | -23.60% | 24.05% | 87.04% |
| Income Tax Expenses | 15.61% | 157.51% | 142.75% | 142.12% | 141.55% |
| Earnings from Continuing Operations | 15.67% | -52.44% | -63.19% | -49.06% | -37.72% |
| Earnings from Discontinued Operations | -- | -100.00% | -89.59% | 103.70% | 104.57% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.52% | -53.85% | -63.81% | -44.56% | -27.15% |
| EBIT | 7.72% | -15.23% | -31.72% | 7.11% | 59.81% |
| EBITDA | 20.53% | 1.64% | -19.61% | 16.36% | 61.20% |
| EPS Basic | 13.83% | -56.24% | -65.59% | -46.54% | -25.83% |
| Normalized Basic EPS | 11.38% | -14.42% | -31.56% | 2.24% | 54.52% |
| EPS Diluted | 12.42% | -54.89% | -65.06% | -44.86% | -23.25% |
| Normalized Diluted EPS | 11.54% | -9.96% | -24.81% | 20.70% | 95.35% |
| Average Basic Shares Outstanding | 0.59% | 5.36% | 11.26% | 18.20% | 26.13% |
| Average Diluted Shares Outstanding | 0.39% | 0.43% | -0.03% | 0.24% | 6.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |